How long do albuterol side effects last
Pro Research Analysisby 
Searched over 200M research papers
Duration of Albuterol Side Effects: An Overview
Introduction to Albuterol and Its Uses
Albuterol is a beta2-adrenergic receptor-selective drug commonly used to treat asthma by relaxing airway smooth muscle. It is available in various forms, including oral tablets, syrup, and metered-dose inhalers (MDIs) . While effective in managing asthma symptoms, albuterol can produce several side effects, which vary in duration and intensity depending on the mode of administration and dosage.
Common Side Effects of Albuterol
Metabolic and Cardiovascular Effects
Albuterol can cause several metabolic changes, such as decreased levels of plasma potassium, phosphate, calcium, and magnesium, and increased levels of plasma glucose, insulin, renin, lactate, and ketones. Cardiovascular effects include peripheral vasodilation, decreased systemic and pulmonary vascular resistance, increased pulse pressure, and tachycardia . These side effects are more pronounced with parenteral administration and less common with aerosol administration due to lower systemic concentrations .
Skeletal Muscle Tremor
Another common side effect is skeletal muscle tremor, which is dose-related and more frequent with higher doses of albuterol .
Duration of Side Effects
Pharmacokinetics and Duration
The pharmacokinetic profile of albuterol indicates a terminal half-life of 3 to 8 hours, suggesting that side effects could last within this timeframe . However, the duration can vary based on the form of albuterol used.
Oral Administration
In a study involving asthmatic children, the effects of oral albuterol (syrup and tablets) were observed to peak at different times. The syrup formulation reached its maximum effect at four hours and lasted for six hours, while the tablet form peaked at two hours and was minimal after five hours . This suggests that side effects from oral albuterol could last up to six hours, with the syrup form potentially causing more prolonged side effects compared to tablets.
Inhalation Administration
When administered via a metered-dose inhaler, albuterol's bronchodilatory effects are rapid and last approximately four hours, with minimal side effects reported . This shorter duration of action implies that side effects from inhaled albuterol are likely to be transient and less severe compared to oral or parenteral forms.
Comparison with Other Beta2-Agonists
Formoterol and Levalbuterol
Studies comparing albuterol with other beta2-agonists like formoterol and levalbuterol indicate that these alternatives may offer longer-lasting bronchodilation with fewer side effects. Formoterol, for instance, provides bronchodilation for up to 12 hours with a similar safety profile to albuterol . Levalbuterol, the active enantiomer of racemic albuterol, has shown a better therapeutic index and reduced beta-adrenergic side effects compared to racemic albuterol .
Conclusion
The duration of albuterol side effects generally aligns with its pharmacokinetic profile, lasting between 3 to 8 hours. The form of administration significantly influences the duration and intensity of these side effects, with inhaled forms typically causing fewer and shorter-lasting side effects compared to oral or parenteral forms. Understanding these differences can help in optimizing asthma management and minimizing adverse effects.
Sources and full results
Most relevant research papers on this topic
A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
Formoterol delivered via the Aerolizer inhaler is an effective and safe treatment for patients with mild to moderate persistent asthma, improving lung function and reducing rescue medication use.
DOI
Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
Levalbuterol provides a better therapeutic index than racemic albuterol for asthma patients, with greater bronchodilation and reduced side effects.
A clinical comparison of terbutaline with albuterol administered by metered-dose inhaler.
Both albuterol and terbutaline effectively cause rapid bronchodilation in asthmatics, with minimal side effects and no statistically significant difference in pulmonary response or side effects.
Comparison of albuterol and metaproterenol syrup in the treatment of childhood asthma.
Albuterol syrup has therapeutic advantages over metaproterenol syrup in improving pulmonary function, chronotropic effects, and frequency of dosing in children with mild to moderate asthma.
Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
Extended-release albuterol tablets (4 mg) effectively improved pulmonary function and asthmatic symptoms in children aged 6-12 years, with no serious treatment-related adverse events.
DOI